Thomas J. Polascik, MD
Director, Society of Urologic Oncology Program
Director, Genitourinary Program on Focal Therapy
Department / Division
Surgery /
Urology
Address
DUMC 2804
Durham, NC 27710
Appointment Telephone
919-668-8108
Office Telephone
919-684-4946
Fax Telephone
919-684-5220
- MD, University of Chicago Pritzker School of Medicine (Illinois), 1991
- General Surgery, Johns Hopkins Hospital (Maryland), 1991-1993
- Urology, James Buchanan Brady Urological Institute, Johns Hopkins Hospital (Maryland), 1993-1997
- Urologic Oncology, Johns Hopkins Hospital (Maryland), 1997-1998
- Fellow, American College of Surgeons
Clinical Interests
Robotic nerve-sparing prostate surgery; nerve-sparing focal therapy (cryosurgery, laser, hemiablation) for prostate cancer; minimally invasive (robotic, laparoscopic, cryotherapy) surgery for kidney tumors; urologic oncology
Research Interests
Prostate cancer imaging
Focal therapy of prostate cancer
Prostate cancer outcomes
Kidney cancer outcomes
Minimally invasive surgery
Nerve sparing cryotherapy
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- AngioDynamic
- Endo Pharmaceuticals
- Galil Medical
Representative Publications
Tsivian, M; Caso, JR; Kimura, M; Polascik, TJ. Renal tumors in solid organ recipients: clinical and pathologic features. Urologic Oncology: seminars and original investigations. 2013;31:255-258.
(2013)
Abstract
Abern, MR; Tsivian, M; Polascik, TJ. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria. Current Urology Reports. 2012;13:160-169.
(2012)
Abstract
Ahmed, HU; Akin, O; Coleman, JA; Crane, S; Emberton, M; Goldenberg, L; Hricak, H; Kattan, MW; Kurhanewicz, J; Moore, CM; Parker, C; Polascik, TJ; Scardino, P; van As, N; Villers, A; Transatlantic Consensus Group on Active Surveillance and Focal Therapy for Prostate Cancer (appendix). Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer. BJU International. 2012;109:1636-1647.
(2012)
Abstract
Baust, JM; Klossner, DP; Robilotto, A; Vanbuskirk, RG; Gage, AA; Mouraviev, V; Polascik, TJ; Baust, JG. Vitamin D(3) cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis. BJU International. 2012;109:949-958.
(2012)
Abstract
Caso, JR; Tsivian, M; Mouraviev, V; Kimura, M; Polascik, TJ. Complications and postoperative events after cryosurgery for prostate cancer. BJU International. 2012;109:840-845.
(2012)
Abstract
Caso, JR; Tsivian, M; Mouraviev, V; Polascik, TJ. Predicting biopsy-proven prostate cancer recurrence following cryosurgery. Urologic Oncology: seminars and original investigations. 2012;30:391-395.
(2012)
Abstract
Kimura, M; Bañez, LL; Gerber, L; Qi, J; Tsivian, M; Freedland, SJ; Satoh, T; Polascik, TJ; Baba, S; Moul, JW. Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database. Journal of Sexual Medicine. 2012;9:1174-1181.
(2012)
Abstract
Stewart, SB; Bañez, LL; Robertson, CN; Freedland, SJ; Polascik, TJ; Xie, D; Koontz, BF; Vujaskovic, Z; Lee, WR; Armstrong, AJ; Febbo, PG; George, DJ; Moul, JW. Utilization trends at a multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center. Journal of Urology. 2012;187:103-108.
(2012)
Abstract
Tsivian, M; Kim, CY; Caso, JR; Rosenberg, MD; Nelson, RC; Polascik, TJ. Contrast enhancement on computed tomography after renal cryoablation: an evidence of treatment failure?. Journal of Endourology. 2012;26:330-335.
(2012)
Abstract
Tsivian, M; Moreira, DM; Sun, L; Mouraviev, V; Kimura, M; Moul, JW; Polascik, TJ. Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight. Urologic Oncology: seminars and original investigations. 2012;30:21-25.
(2012)
Abstract
Tsivian, M; Polascik, TJ. Prostate cancer: ideal candidates for focal therapy. Nature Reviews Urology. 2012;9:12-13.
(2012)
Abstract
Tsivian, M; Qi, P; Kimura, M; Chen, VH; Chen, SH; Gan, TJ; Polascik, TJ. The effect of noise-cancelling headphones or music on pain perception and anxiety in men undergoing transrectal prostate biopsy. Urology. 2012;79:32-36.
(2012)
Abstract
Tsivian, M; Wright, T; Price, M; Mouraviev, V; Madden, JF; Kimura, M; Wong, T; Polascik, TJ. 111-In-capromab pendetide imaging using hybrid-¿ camera-computer tomography technology is not reliable in detecting seminal vesicle invasion in patients with prostate cancer. Urologic Oncology: seminars and original investigations. 2012;30:150-154.
(2012)
Abstract
Wattson, DA; Chen, MH; Moul, JW; Moran, BJ; Dosoretz, DE; Robertson, CN; Polascik, TJ; Braccioforte, MH; Salenius, SA; D'Amico, AV. The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selection. International Journal of Radiation: Oncology - Biology - Physics. 2012;82:e773-e779.
(2012)
Abstract
Zhai, L; Polascik, TJ; Foo, WC; Rosenzweig, S; Palmeri, ML; Madden, J; Nightingale, KR. Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration. Ultrasound in Medicine and Biology. 2012;38:50-61.
(2012)
Abstract
Cotter, SE; Chen, MH; Moul, JW; Lee, WR; Koontz, BF; Anscher, MS; Robertson, CN; Walther, PJ; Polascik, TJ; D'Amico, AV. Salvage radiation in men after prostate-specific antigen failure and the risk of death. Cancer. 2011;117:3925-3932.
(2011)
Abstract
Heymach, JV; Shackleford, TJ; Tran, HT; Yoo, SY; Do, KA; Wergin, M; Saintigny, P; Vollmer, RT; Polascik, TJ; Snyder, DC; Ruffin, MT; Yan, S; Dewhirst, M; Kunnumakkara, AB; Aggarwal, BB; Demark-Wahnefried, W. Effect of low-fat diets on plasma levels of NF-¿B-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer. Cancer Prevention Research. 2011;4:1590-1598.
(2011)
Abstract
Kimura, M; Bañez, LL; Schroeck, FR; Gerber, L; Qi, J; Satoh, T; Baba, S; Robertson, CN; Walther, PJ; Donatucci, CF; Moul, JW; Polascik, TJ. Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy. Journal of Sexual Medicine. 2011;8:2935-2943.
(2011)
Abstract
Kimura, M; Donatucci, CF; Tsivian, M; Caso, JR; Moreira, DM; Mouraviev, V; Satoh, T; Baba, S; Polascik, TJ. On-demand use of erectile aids in men with preoperative erectile dysfunction treated by whole gland prostate cryoablation. International Journal of Impotence Research. 2011;23:49-55.
(2011)
Abstract
Kimura, M; Yan, H; Rabbani, Z; Satoh, T; Baba, S; Yin, FF; Polascik, TJ; Donatucci, CF; Vujaskovic, Z; Koontz, BF. Radiation-induced erectile dysfunction using prostate-confined modern radiotherapy in a rat model. Journal of Sexual Medicine. 2011;8:2215-2226.
(2011)
Abstract
Matvey, T; Polascik, TJ. Editorial comment. Urology. 2011;77:1152-1153.
(2011)
Abstract
Mayes, JM; Mouraviev, V; Sun, L; Tsivian, M; Madden, JF; Polascik, TJ. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?. Urologic Oncology: seminars and original investigations. 2011;29:166-170.
(2011)
Abstract
Mouraviev, V; Polascik, TJ. New Frontiers in Imaging and Focal Therapy: Highlights From the Third International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer, February 24-27, 2010, Washington, DC. Reviews in Urology. 2011;13:104-111.
(2011)
Abstract
Mouraviev, V; Venkatraman, TN; Tovmasyan, A; Kimura, M; Tsivian, M; Mouravieva, V; Polascik, TJ; Wang, H; Amrhein, TJ; Batinic-Haberle, I; Lascola, C. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents. Journal of Endourology. 2011;1420-1424.
(2011)
Abstract
Mouraviev, V; Villers, A; Bostwick, DG; Wheeler, TM; Montironi, R; Polascik, TJ. Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy. BJU International. 2011;108:1074-1085.
(2011)
Abstract
Rosenberg, MD; Kim, CY; Tsivian, M; Suberlak, MN; Sopko, DR; Polascik, TJ; Nelson, RC. Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications. American Journal of Roentgenology. 2011;196:935-939.
(2011)
Abstract
Santucci, KL; Snyder, KK; Baust, JM; Van Buskirk, RG; Mouraviev, V; Polascik, TJ; Gage, AA; Baust, JG. Use of 1,25¿ dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model. Prostate Cancer and Prostatic Diseases. 2011;14:97-104.
(2011)
Abstract
Tang, P; Sun, L; Uhlman, MA; Robertson, CN; Polascik, TJ; Moul, JW. Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men. BJU International. 2011;108:44-48.
(2011)
Abstract
Tsivian, M; Caso, J; Kimura, M; Polascik, TJ. Renal function outcomes after laparoscopic renal cryoablation. Journal of Endourology. 2011;25:1287-1291.
(2011)
Abstract
Tsivian, M; Moreira, DM; Caso, JR; Mouraviev, V; Polascik, TJ. Cigarette smoking is associated with advanced renal cell carcinoma. Journal of Clinical Oncology. 2011;29:2027-2031.
(2011)
Abstract
Tsivian, M; Mouraviev, V; Albala, DM; Caso, JR; Robertson, CN; Madden, JF; Polascik, TJ. Clinical predictors of renal mass pathological features. BJU International. 2011;107:735-740.
(2011)
Abstract
Tsivian, M; Polascik, TJ. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy. BJU International. 2011;108:371.
(2011)
Abstract
Van Poppel, H; Becker, F; Cadeddu, JA; Gill, IS; Janetschek, G; Jewett, MA; Laguna, MP; Marberger, M; Montorsi, F; Polascik, TJ; Ukimura, O; Zhu, G. Treatment of localised renal cell carcinoma. European Urology. 2011;60:662-672.
(2011)
Abstract
Baust, JG; Klossner, DP; Vanbuskirk, RG; Gage, AA; Mouraviev, V; Polascik, TJ; Baust, JM. Integrin involvement in freeze resistance of androgen-insensitive prostate cancer. Prostate Cancer and Prostatic Diseases. 2010;13:151-161.
(2010)
Abstract
Caire, AA; Sun, L; Lack, BD; Lum, K; Tang, P; Stackhouse, DA; Robertson, CN; Mouraviev, V; Polascik, TJ; Albala, DM; Moul, JW. Predicting non-organ-confined prostate cancer in men diagnosed after 2000. Prostate Cancer and Prostatic Diseases. 2010;13:248-251.
(2010)
Abstract
Caire, AA; Sun, L; Polascik, TJ; Albala, DM; Moul, JW. Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans. BJU International. 2010;106:1157-1160.
(2010)
Abstract
Caire, AA; Sun, L; Robertson, CN; Polascik, TJ; Maloney, KE; George, DJ; Price, MM; Stackhouse, DA; Lack, BD; Albala, DM; Moul, JW. Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75. Urology. 2010;75:1122-1127.
(2010)
Abstract
Caso, JR; Mouraviev, V; Tsivian, M; Polascik, TJ; Moul, JW. Prostate cancer: an evolving paradigm. Journal of Endourology. 2010;24:805-809.
(2010)
Abstract
Caso, JR; Tsivian, M; Mouraviev, V; Polascik, TJ; Moul, JW. Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer. BJU International. 2010;106:1623-1627.
(2010)
Abstract
Choueiri, TK; Chen, MH; D'Amico, AV; Sun, L; Nguyen, PL; Hayes, JH; Robertson, CN; Walther, PJ; Polascik, TJ; Albala, DM; Moul, JW. Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death. Cancer. 2010;116:1887-1892.
(2010)
Abstract
D'Amico, AV; Chen, MH; Sun, L; Lee, WR; Mouraviev, V; Robertson, CN; Walther, PJ; Polascik, TJ; Albala, DM; Moul, JW. Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death. BJU International. 2010;106:1618-1622.
(2010)
Abstract
Eggener, S; Salomon, G; Scardino, PT; De la Rosette, J; Polascik, TJ; Brewster, S. Focal therapy for prostate cancer: possibilities and limitations. European Urology. 2010;58:57-64.
(2010)
Abstract
Kimura, M; Baba, S; Polascik, TJ. Minimally invasive surgery using ablative modalities for the localized renal mass. International Journal of Urology. 2010;17:215-227.
(2010)
Abstract
Kimura, M; Mouraviev, V; Tsivian, M; Mayes, JM; Satoh, T; Polascik, TJ. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU International. 2010;105:191-201.
(2010)
Abstract
Kimura, M; Mouraviev, V; Tsivian, M; Moreira, DM; Mayes, JM; Polascik, TJ. Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation. Urology. 2010;76:1258-1265.
(2010)
Abstract
Kimura, M; Rabbani, Z; Mouraviev, V; Tsivian, M; Caso, J; Satoh, T; Baba, S; Vujaskovic, Z; Baust, JM; Baust, JG; Polascik, TJ. Role of vitamin D(3) as a sensitizer to cryoablation in a murine prostate cancer model: preliminary in vivo study. Urology. 2010;76:764.e14-764.e20.
(2010)
Abstract
Kimura, M; Rabbani, Z; Mouraviev, V; Tsivian, M; Vujaskovic, Z; Satoh, T; Baba, S; Baust, JM; Baust, JG; Polascik, TJ. Morphology of hypoxia following cryoablation in a prostate cancer murine model: its relationship to necrosis, apoptosis and, microvessel density. Cryobiology. 2010;61:148-154.
(2010)
Abstract
Mouraviev, V; Johansen, TE; Polascik, TJ. Contemporary results of focal therapy for prostate cancer using cryoablation. Journal of Endourology. 2010;24:827-834.
(2010)
Abstract
Tang, P; Sun, L; Uhlman, MA; Polascik, TJ; Freedland, SJ; Moul, JW. Baseline PSA as a predictor of prostate cancer-specific mortality over the past 2 decades: Duke University experience. Cancer. 2010;116:4711-4717.
(2010)
Abstract
Tang, P; Sun, L; Uhlman, MA; Robertson, CN; Polascik, TJ; Albala, DM; Donatucci, CF; Moul, JW. Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk. Journal of Urology. 2010;183:946-950.
(2010)
Abstract
Tang, P; Sun, L; Uhlman, MA; Robertson, CN; Polascik, TJ; Albala, DM; Donatucci, CF; Moul, JW. Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men. Urology. 2010;76:1058-1062.
(2010)
Abstract
Tsivian, M; Chen, VH; Kim, CY; Zilberman, DE; Mouraviev, V; Nelson, RC; Albala, DM; Polascik, TJ. Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center. European Urology. 2010;58:142-147.
(2010)
Abstract
Tsivian, M; Hruza, M; Mouraviev, V; Rassweiler, J; Polascik, TJ. Prostate biopsy in selecting candidates for hemiablative focal therapy. Journal of Endourology. 2010;24:849-853.
(2010)
Abstract
Tsivian, M; Kimura, M; Sun, L; Mouraviev, V; Mayes, JM; Polascik, TJ. Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended. BJU International. 2010;105:1089-1092.
(2010)
Abstract
Tsivian, M; Lyne, JC; Mayes, JM; Mouraviev, V; Kimura, M; Polascik, TJ. Tumor size and endophytic growth pattern affect recurrence rates after laparoscopic renal cryoablation. Urology. 2010;75:307-310.
(2010)
Abstract
Tsivian, M; Moreira, DM; Caso, JR; Mouraviev, V; Madden, JF; Bratslavsky, G; Robertson, CN; Albala, DM; Polascik, TJ. Predicting occult multifocality of renal cell carcinoma. European Urology. 2010;58:118-126.
(2010)
Abstract
Tsivian, M; Polascik, TJ. Editorial comment. Urology. 2010;76:687.
(2010)
Abstract
Tsivian, M; Polascik, TJ. Focal cryotherapy for prostate cancer. Current Urology Reports. 2010;11:147-151.
(2010)
Abstract
Tsivian, M; Polascik, TJ. Recent advances in focal therapy of prostate and kidney cancer. F1000 Medicine Reports. 2010;2.
(2010)
Abstract
Uhlman, MA; Sun, L; Stackhouse, DA; Caire, AA; Polascik, TJ; Robertson, CN; Madden, J; Vollmer, R; Albala, DM; Moul, JW. Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?. Urology. 2010;75:460-466.
(2010)
Abstract
Uhlman, MA; Sun, L; Stackhouse, DA; Polascik, TJ; Mouraviev, V; Robertson, CN; Albala, DM; Moul, JW. Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate. Journal of Urology. 2010;183:997-1001.
(2010)
Abstract
Zhai, L; Madden, J; Foo, WC; Mouraviev, V; Polascik, TJ; Palmeri, ML; Nightingale, KR. Characterizing stiffness of human prostates using acoustic radiation force. Ultrasonic Imaging. 2010;32:201-213.
(2010)
Abstract
Zhai, L; Madden, J; Foo, WC; Palmeri, ML; Mouraviev, V; Polascik, TJ; Nightingale, KR. Acoustic radiation force impulse imaging of human prostates ex vivo. Ultrasound in Medicine and Biology. 2010;36:576-588.
(2010)
Abstract
Caire, AA; Sun, L; Ode, O; Stackhouse, DA; Maloney, K; Donatucci, C; Mouraviev, V; Polascik, TJ; Robertson, CN; Albala, DM; Moul, JW. Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?. Urology. 2009;74:643-647.
(2009)
Abstract
Chen, VH; Mouraviev, V; Mayes, JM; Sun, L; Madden, JF; Moul, JW; Polascik, TJ. Utility of a 3-dimensional transrectal ultrasound-guided prostate biopsy system for prostate cancer detection. Technology in Cancer Research and Treatment. 2009;8:99-104.
(2009)
Abstract
D'Alonzo, RC; Gan, TJ; Moul, JW; Albala, DM; Polascik, TJ; Robertson, CN; Sun, L; Dahm, P; Habib, AS. A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomy. Journal of Clinical Anesthesia. 2009;21:322-328.
(2009)
Abstract
Habib, AS; Polascik, TJ; Weizer, AZ; White, WD; Moul, JW; ElGasim, MA; Gan, TJ. Lidocaine patch for postoperative analgesia after radical retropubic prostatectomy. Anesthesia and Analgesia. 2009;108:1950-1953.
(2009)
Abstract
Kimura, M; Tsivian, M; Mouraviev, V; Mayes, JM; Price, MM; Bannister, MC; Madden, JF; Wong, TZ; Polascik, TJ. Utilization of (111)In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy. International Journal of Urology. 2009;16:971-975.
(2009)
Abstract
Mayes, JM; Mouraviev, V; Tsivian, M; Krupski, TL; Donatucci, CF; Polascik, TJ. Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer. International Journal of Impotence Research. 2009;21:253-260.
(2009)
Abstract
Moul, JW; Mouraviev, V; Sun, L; Schroeck, FR; Polascik, TJ. Prostate cancer: the new landscape. Current Opinion in Urology. 2009;19:154-160.
(2009)
Abstract
Mouraviev, V; Madden, JF; Broadwater, G; Mayes, JM; Burchette, JL; Schneider, F; Smith, J; Tsivian, M; Wong, T; Polascik, TJ. Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland. Journal of Urology. 2009;182:938-947.
(2009)
Abstract
Mouraviev, V; Mayes, JM; Polascik, TJ. Pathologic basis of focal therapy for early-stage prostate cancer. Nature Reviews Urology. 2009;6:205-215.
(2009)
Abstract
Polascik, TJ. Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases. Drug Design, Development and Therapy. 2009;3:27-40.
(2009)
Abstract
Polascik, TJ; Mayes, JM; Mouraviev, V. Nerve-sparing focal cryoablation of prostate cancer. Current Opinion in Urology. 2009;19:182-187.
(2009)
Abstract
Polascik, TJ; Mayes, JM; Schroeck, FR; Sun, L; Madden, JF; Moul, JW; Mouraviev, V. Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy. Cancer. 2009;115:2104-2110.
(2009)
Abstract
Polascik, TJ; Mouraviev, V. Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients. Urology. 2009;74:726-730.
(2009)
Abstract
Stackhouse, DA; Sun, L; Schroeck, FR; Jayachandran, J; Caire, AA; Acholo, CO; Robertson, CN; Albala, DM; Polascik, TJ; Donatucci, CF; Maloney, KE; Moul, JW. Factors predicting prostatic biopsy Gleason sum under grading. Journal of Urology. 2009;182:118-122.
(2009)
Abstract
Sun, L; Caire, AA; Robertson, CN; George, DJ; Polascik, TJ; Maloney, KE; Walther, PJ; Stackhouse, DA; Lack, BD; Albala, DM; Moul, JW. Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras. Journal of Urology. 2009;182:2242-2248.
(2009)
Abstract
Tsivian, M; Mayes, JM; Krupski, TL; Mouraviev, V; Donatucci, CF; Polascik, TJ. Altered male physiologic function after surgery for prostate cancer: couple perspective. International braz j urol : official journal of the Brazilian Society of Urology. 2009;35:673-682.
(2009)
Abstract
Tsivian, M; Sun, L; Mouraviev, V; Madden, JF; Mayes, JM; Moul, JW; Polascik, TJ. Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy. Urology. 2009;74:1090-1093.
(2009)
Abstract
Chen, VH; Mayes, JM; Madden, JF; Stein, AJ; Mouraviev, V; Polascik, TJ. The effect of cryoablation on the histologic interpretation of intraoperative biopsy of small clear cell renal carcinoma and renal oncocytoma. Journal of Endourology. 2008;22:1617-1621.
(2008)
Abstract
Chen, VH; Mayes, JM; Mouraviev, V; Polascik, TJ. Urothelial sloughing with obstruction after laparoscopic cryoablation of small renal carcinoma in solitary kidney. Urology. 2008;72:716.e1-716.e2.
(2008)
Abstract
Demark-Wahnefried, W; George, SL; Switzer, BR; Snyder, DC; Madden, JF; Polascik, TJ; Ruffin, MT; Vollmer, RT. Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer. Clinical Trials. 2008;5:262-272.
(2008)
Abstract
Demark-Wahnefried, W; Polascik, TJ; George, SL; Switzer, BR; Madden, JF; Ruffin, MT; Snyder, DC; Owzar, K; Hars, V; Albala, DM; Walther, PJ; Robertson, CN; Moul, JW; Dunn, BK; Brenner, D; Minasian, L; Stella, P; Vollmer, RT. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiology, Biomarkers and Prevention. 2008;17:3577-3587.
(2008)
Abstract
Habib, AS; White, WD; El Gasim, MA; Saleh, G; Polascik, TJ; Moul, JW; Gan, TJ. Transdermal nicotine for analgesia after radical retropubic prostatectomy. Anesthesia and Analgesia. 2008;107:999-1004.
(2008)
Abstract
Isariyawongse, BK; Sun, L; Bañez, LL; Robertson, C; Polascik, TJ; Maloney, K; Donatucci, C; Albala, D; Mouraviev, V; Madden, JF; Moul, JW. Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen. Urology. 2008;72:882-886.
(2008)
Abstract
Koontz, BF; Mouraviev, V; Johnson, JL; Mayes, J; Chen, SH; Wong, TZ; Anscher, MS; Sun, L; Moul, J; Polascik, TJ. Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer. International Journal of Radiation: Oncology - Biology - Physics. 2008;71:358-361.
(2008)
Abstract
Mayes, JM; Mouraviev, V; Polascik, TJ. Impact of a cryotherapy training workshop on the adoption and utilization of cryotherapy in the community setting. Canadian Journal of Urology. 2008;15:4147-4152.
(2008)
Abstract
Mayes, JM; Mouraviev, V; Sun, L; Madden, JF; Polascik, TJ. WITHDRAWN: Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?. Prostate Cancer and Prostatic Diseases. 2008;
(2008)
Abstract
Megwalu, II; Ferguson, GG; Wei, JT; Mouraviev, V; Polascik, TJ; Taneja, S; Black, L; Andriole, GL; Kibel, AS. Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer. BJU International. 2008;102:546-550.
(2008)
Abstract
Mouraviev, V; Broadwater, G; Sun, L; Mayes, JM; Moul, JW; Polascik, TJ. Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?. Urology. 2008;71:1020-1023.
(2008)
Abstract
Polascik, TJ. Bone health in prostate cancer patients receiving androgen-deprivation therapy: the role of bisphosphonates. Prostate Cancer and Prostatic Diseases. 2008;11:13-19.
(2008)
Abstract
Polascik, TJ; Mayes, JM; Mouraviev, V. From whole-gland to targeted cryoablation for the treatment of unilateral or focal prostate cancer. Oncology. 2008;22:900-906.
(2008)
Abstract
Polascik, TJ; Mayes, JM; Sun, L; Madden, JF; Moul, JW; Mouraviev, V. Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. The Prostate. 2008;68:1380-1386.
(2008)
Abstract
Polascik, TJ; Mouraviev, V. Focal therapy for prostate cancer. Current Opinion in Urology. 2008;18:269-274.
(2008)
Abstract
Polascik, TJ; Mouraviev, V. Zoledronic acid in the management of metastatic bone disease. Therapeutics and Clinical Risk Management. 2008;4:261-268.
(2008)
Abstract
Schroeck, FR; Donatucci, CF; Smathers, EC; Sun, L; Albala, DM; Polascik, TJ; Moul, JW; Krupski, TL. Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite. Cancer. 2008;113:2687-2694.
(2008)
Abstract
Schroeck, FR; Krupski, TL; Sun, L; Albala, DM; Price, MM; Polascik, TJ; Robertson, CN; Tewari, AK; Moul, JW. Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. European Urology. 2008;54:785-793.
(2008)
Abstract
Schroeck, FR; Sun, L; Freedland, SJ; Albala, DM; Mouraviev, V; Polascik, TJ; Moul, JW. Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy. BJU International. 2008;102:28-32.
(2008)
Abstract
Stein, AJ; Mayes, JM; Mouraviev, V; Chen, VH; Nelson, RC; Polascik, TJ. Persistent contrast enhancement several months after laparoscopic cryoablation of the small renal mass may not indicate recurrent tumor. Journal of Endourology. 2008;22:2433-2439.
(2008)
Abstract
Chen, SH; Mouraviev, V; Mayes, JM; Polascik, TJ. Prostatic abscess as a delayed complication following cryosurgery for primary prostate cancer. Canadian Journal of Urology. 2007;14:3646-3648.
(2007)
Abstract
Chen, SH; Mouraviev, V; Raj, GV; Marguet, CG; Polascik, TJ. Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma. Urology. 2007;69:982.e3-982.e5.
(2007)
Abstract
Marguet, C; Raj, GV; Brashears, JH; Anscher, MS; Ludwig, K; Mouraviev, V; Robertson, CN; Polascik, TJ. Rectourethral fistula after combination radiotherapy for prostate cancer. Urology. 2007;69:898-901.
(2007)
Abstract
Moul, JW; Sun, L; Hotaling, JM; Fitzsimons, NJ; Polascik, TJ; Robertson, CN; Dahm, P; Anscher, MS; Mouraviev, V; Pappas, PA; Albala, DM. Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. Journal of Urology. 2007;177:499-503.
(2007)
Abstract
Mouraviev, V; Joniau, S; Van Poppel, H; Polascik, TJ. Current status of minimally invasive ablative techniques in the treatment of small renal tumours. European Urology. 2007;51:328-336.
(2007)
Abstract
Mouraviev, V; Mayes, JM; Madden, JF; Sun, L; Polascik, TJ. Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy. Technology in Cancer Research and Treatment. 2007;6:91-95.
(2007)
Abstract
Mouraviev, V; Mayes, JM; Sun, L; Madden, JF; Moul, JW; Polascik, TJ. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer. 2007;110:906-910.
(2007)
Abstract
Mouraviev, V; Nosnik, I; Robertson, C; Albala, D; Walther, P; Polascik, TJ. Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience. European Urology. 2007;51:715-720.
(2007)
Abstract
Mouraviev, V; Nosnik, I; Sun, L; Robertson, CN; Walther, P; Albala, D; Moul, JW; Polascik, TJ. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience. Urology. 2007;69:311-314.
(2007)
Abstract
Mouraviev, V; Sun, L; Madden, JF; Mayes, JM; Moul, JW; Polascik, TJ. Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy. Urology. 2007;70:1141-1145.
(2007)
Abstract
Polascik, TJ; Mouraviev, V. The rise of ablative technologies for treating the small renal mass. European Urology. 2007;52:636-638.
(2007)
Abstract
Polascik, TJ; Nosnik, I; Mayes, JM; Mouraviev, V. Short Term Clinical Outcome after Laparoscopic Cryoablation of the Renal Tumor < or = 3.5 cm. Technology in Cancer Research and Treatment. 2007;6:621-624.
(2007)
Abstract
Polascik, TJ; Nosnik, I; Mayes, JM; Mouraviev, V. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology. 2007;70:117-121.
(2007)
Abstract
Sun, L; Moul, JW; Hotaling, JM; Rampersaud, E; Dahm, P; Robertson, C; Fitzsimons, N; Albala, D; Polascik, TJ. Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. British Journal of Urology (BJU) International. 2007;99:753-757.
(2007)
Abstract
Tseng, TY; Cancel, QV; Fesperman, SF; Kuebler, HR; Sun, L; Robertson, CN; Polascik, TJ; Moul, JW; Vieweg, J; Albala, DM; Dahm, P. The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy. Journal of Urology. 2007;177:1318-1323.
(2007)
Abstract
Auge, BK; Santa-Cruz, RW; Polascik, TJ. Effect of freeze time during renal cryoablation: a swine model. Journal of Endourology. 2006;20:1101-1105.
(2006)
Abstract
Mouraviev, V; Evans, B; Polascik, TJ. Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach. Prostate Cancer and Prostatic Diseases. 2006;9:99-101.
(2006)
Abstract
Mouraviev, V; Polascik, TJ. Update on cryotherapy for prostate cancer in 2006. Current Opinion in Urology. 2006;16:152-156.
(2006)
Abstract
Nosnik, IP; Mouraviev, V; Nelson, R; Polascik, TJ. Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma. Urology. 2006;68:1343.e1-1343.e3.
(2006)
Abstract
Raj, GV; Yowell, C; Madden, JF; Nosnik, I; Mouraviev, V; Polascik, TJ. Malignant cystic nephroma. Canadian Journal of Urology. 2006;13:3348-3350.
(2006)
Abstract
Wiygul, JB; Lallas, C; Silverstein, A; Polascik, TJ. Ovarian hyperstimulation causing ureteral obstruction in a pregnant woman. Urology. 2006;67:1085.e5-1085.e6.
(2006)
Abstract
Brashears, JH; Raj, GV; Crisci, A; Young, MD; Dylewski, D; Nelson, R; Madden, JF; Polascik, TJ. Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. Journal of Urology. 2005;173:2160-2165.
(2005)
Abstract
Polascik, TJ; Given, RW; Metzger, C; Julian, SR; Vestal, JC; Karlin, GS; Barkley, CS; Bilhartz, DL; McWhorter, LT; Lacerna, LV. Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases. Urology. 2005;66:1054-1059.
(2005)
Abstract
Raj, GV; Brashears, JH; Anand, A; Paulson, DF; Polascik, TJ. Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?. Urology. 2005;65:332-336.
(2005)
Abstract
Weizer, AZ; Raj, GV; O'Connell, M; Robertson, CN; Nelson, RC; Polascik, TJ. Complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005;66:1176-1180.
(2005)
Abstract
Wiygul, JB; Evans, BR; Peterson, BL; Polascik, TJ; Walther, PJ; Robertson, CN; Albala, DM; Demark-Wahnefried, W. Supplement use among men with prostate cancer. Urology. 2005;66:161-166.
(2005)
Abstract
Wong, TZ; Turkington, TG; Polascik, TJ; Coleman, RE. ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology. American Journal of Roentgenology. 2005;184:676-680.
(2005)
Abstract
Demark-Wahnefried, W; Robertson, CN; Walther, PJ; Polascik, TJ; Paulson, DF; Vollmer, RT. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology. 2004;63:900-904.
(2004)
Abstract
Dulaimi, E; Ibanez de Caceres, I; Uzzo, RG; Al-Saleem, T; Greenberg, RE; Polascik, TJ; Babb, JS; Grizzle, WE; Cairns, P. Promoter hypermethylation profile of kidney cancer. Clinical Cancer Research. 2004;10:3972-3979.
(2004)
Abstract
Raj, GV; Ellington, KS; Polascik, TJ. Autoimmune testicular vasculitis. Urology. 2003;61:1035.
(2003)
Abstract
Raj, GV; Reddan, DJ; Hoey, MF; Polascik, TJ. Management of small renal tumors with radiofrequency ablation. Urology. 2003;61:23-29.
(2003)
Abstract
Santa-Cruz, RW; Auge, BK; Lallas, CD; Preminger, GM; Polascik, TJ. Use of bipolar laparoscopic forceps to occlude and transect the retroperitoneal vasculature: a porcine model. Journal of Endourology. 2003;17:181-185.
(2003)
Abstract
Munver, R; Threatt, CB; Delvecchio, FC; Preminger, GM; Polascik, TJ. Hypertonic saline-augmented radiofrequency ablation of the VX-2 tumor implanted in the rabbit kidney: a short-term survival pilot study. Urology. 2002;60:170-175.
(2002)
Abstract
Polascik, TJ; Bostwick, DG; Cairns, P. Molecular genetics and histopathologic features of adult distal nephron tumors. Urology. 2002;60:941-946.
(2002)
Abstract
Price, DT; Coleman, RE; Liao, RP; Robertson, CN; Polascik, TJ; DeGrado, TR. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. Journal of Urology. 2002;168:273-280.
(2002)
Abstract
Raj, GV; Partin, AW; Polascik, TJ. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. Cancer. 2002;94:987-996.
(2002)
Abstract
DeGrado, TR; Coleman, RE; Wang, S; Baldwin, SW; Orr, MD; Robertson, CN; Polascik, TJ; Price, DT. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Research. 2001;61:110-117.
(2001)
Abstract
Demark-Wahnefried, W; Price, DT; Polascik, TJ; Robertson, CN; Anderson, EE; Paulson, DF; Walther, PJ; Gannon, M; Vollmer, RT. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001;58:47-52.
(2001)
Abstract
Reddan, DN; Raj, GV; Polascik, TJ. Management of small renal tumors: an overview. American Journal of Medicine. 2001;110:558-562.
(2001)
Abstract
Rosenthal, SA; Haseman, MK; Polascik, TJ. Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer. Techniques in Urology. 2001;7:27-37.
(2001)
Abstract
Haseman, MK; Rosenthal, SA; Polascik, TJ. Capromab Pendetide imaging of prostate cancer. Cancer Biotherapy and Radiopharmaceuticals. 2000;15:131-140.
(2000)
Abstract
Munver, R; Donehower, RC; Kronz, JD; Polascik, TJ. HIV infection presenting as an unusually large pure yolk sac tumor of the testis. Journal of Urology. 2000;164:1653-1654.
(2000)
Abstract
Wolf, JS; Marcovich, R; Gill, IS; Sung, GT; Kavoussi, LR; Clayman, RV; McDougall, EM; Shalhav, A; Dunn, MD; Afane, JS; Moore, RG; Parra, RO; Winfield, HN; Sosa, RE; Chen, RN; Moran, ME; Nakada, SY; Hamilton, BD; Albala, DM; Koleski, F; Das, S; Adams, JB; Polascik, TJ. Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery. Urology. 2000;55:831-836.
(2000)
Abstract
Polascik, TJ; Hamper, U; Lee, BR; Dai, Y; Hilton, J; Magee, CA; Crone, JK; Shue, MJ; Ferrell, M; Trapanotto, V; Adiletta, M; Partin, AW. Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy: preliminary report of a new technology. Urology. 1999;53:465-472.
(1999)
Abstract
Polascik, TJ; Manyak, MJ; Haseman, MK; Gurganus, RT; Rogers, B; Maguire, RT; Partin, AW. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients. Cancer. 1999;85:1586-1592.
(1999)
Abstract
Polascik, TJ; Oesterling, JE; Partin, AW. Prostate specific antigen: a decade of discovery--what we have learned and where we are going. Journal of Urology. 1999;162:293-306.
(1999)
Abstract
Polascik, TJ; Wang, ZP; Shue, M; Di, S; Gurganus, RT; Hortopan, SC; Ts'o, PO; Partin, AW. Influence of sextant prostate needle biopsy or surgery on the detection and harvest of intact circulating prostate cancer cells. Journal of Urology. 1999;162:749-752.
(1999)
Abstract
Polascik, TJ; Chen, RN. Laparoscopic ureteroureterostomy for retrocaval ureter. Journal of Urology. 1998;160:121-122.
(1998)
Abstract
Polascik, TJ; Partin, AW; Pound, CR; Marshall, FF. Frequent occurrence of metastatic disease in patients with renal cell carcinoma and intrahepatic or supradiaphragmatic intracaval extension treated with surgery: an outcome analysis. Urology. 1998;52:995-999.
(1998)
Abstract
Polascik, TJ; Pearson, JD; Partin, AW. Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen. Urologic Oncology: seminars and original investigations. 1998;16:160-171.
(1998)
Abstract
Polascik, TJ; Pearson, JD; Partin, AW; Polascik, DT. Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer. Prostate Cancer and Prostatic Diseases. 1998;1:301-306.
(1998)
Abstract
Polascik, TJ; Pound, CR; DeWeese, TL; Walsh, PC. Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis. Urology. 1998;51:884-889.
(1998)
Abstract
Polascik, TJ; Cairns, P; Epstein, JI; Fuzesi, L; Ro, JY; Marshall, FF; Sidransky, D; Schoenberg, M. Distal nephron renal tumors: microsatellite allelotype. Cancer Research. 1996;56:1892-1895.
(1996)
Abstract
Polascik, TJ; Chan-Tack, KM; Jeffs, RD; Gearhart, JP. Reappraisal of the role of human chorionic gonadotropin in the diagnosis and treatment of the nonpalpable testis: a 10-year experience. Journal of Urology. 1996;156:804-806.
(1996)
Abstract
Steiner, G; Cairns, P; Polascik, TJ; Marshall, FF; Epstein, JI; Sidransky, D; Schoenberg, M. High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2. Cancer Research. 1996;56:5044-5046.
(1996)
Abstract
Cairns, P; Polascik, TJ; Eby, Y; Tokino, K; Califano, J; Merlo, A; Mao, L; Herath, J; Jenkins, R; Westra, W. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genetics. 1995;11:210-212.
(1995)
Abstract
Chang, WY; Cairns, P; Schoenberg, MP; Polascik, TJ; Sidransky, D. Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Research. 1995;55:3246-3249.
(1995)
Abstract
Polascik, TJ; Cairns, P; Chang, WY; Schoenberg, MP; Sidransky, D. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Research. 1995;55:5396-5399.
(1995)
Abstract
Polascik, TJ; Meng, MV; Epstein, JI; Marshall, FF. Intraoperative sonography for the evaluation and management of renal tumors: experience with 100 patients. Journal of Urology. 1995;154:1676-1680.
(1995)
Abstract
Polascik, TJ; Moore, RG; Rosenberg, MT; Kavoussi, LR. Comparison of laparoscopic and open retropubic urethropexy for treatment of stress urinary incontinence. Urology. 1995;45:647-652.
(1995)
Abstract
Polascik, TJ; Pound, CR; Meng, MV; Partin, AW; Marshall, FF. Partial nephrectomy: technique, complications and pathological findings. Journal of Urology. 1995;154:1312-1318.
(1995)
Abstract
Polascik, TJ; Walsh, PC. Radical retropubic prostatectomy: the influence of accessory pudendal arteries on the recovery of sexual function. Journal of Urology. 1995;154:150-152.
(1995)
Abstract
Riopel, MA; Polascik, TJ; Partin, AW; Sauvageot, J; Walsh, PC; Epstein, JI. Radical prostatectomy in men less than 50 years old. Urologic Oncology: seminars and original investigations. 1995;1:80-83.
(1995)
Abstract
